Toxicity information is crucial in making Go/No-Go decisions during drug development.  Biomodels has partnered with CIT to offer both early non-GLP and formal GLP toxicology studies.  Together, Biomodels and CIT can provide all the preclinical testing needed for an IND application.  Alternatively, clients can order “a la carte” from Biomodels list of non-GLP toxicology studies including preliminary toxicology and short-medium term tolerability studies.